{"disease":{"id":"neuropathic-pain-associated-with-diabetic-peripheral-neuropathy","name":"Neuropathic pain associated with diabetic peripheral neuropathy","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"lyrica","indication_name":"Neuropathic pain associated with diabetic peripheral neuropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lyrica","generic_name":"Pregabalin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"alpha-2-delta subunit (auxiliary subunit of voltage-gated calcium channels)","drug_class":"Anticonvulsant, analgesic","quality_score":10,"revenue":null,"mechanism":"Pregabalin binds alpha-2-delta subunit of voltage-gated calcium channels in CNS."},{"drug_id":"lyrica","indication_name":"Neuropathic pain associated with diabetic peripheral neuropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lyrica","generic_name":"Pregabalin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"alpha-2-delta subunit (auxiliary subunit of voltage-gated calcium channels)","drug_class":"Anticonvulsant, analgesic","quality_score":10,"revenue":null,"mechanism":"Pregabalin binds alpha-2-delta subunit of voltage-gated calcium channels in CNS."},{"drug_id":"bat","indication_name":"Treatment of neuropathic pain associated with diabetic peripheral neuropathy in adults","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bat","generic_name":"bat","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Unknown","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04641273","title":"A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic Pain","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":154,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05219812","title":"A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT07162454","title":"Effectiveness of CBD for Neuropathic Pain in Diabetic Foot Neuropathy","phase":"NA","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Universidad Complutense de Madrid","has_results":false}],"total":3},"guidelines":[{"drug_id":"lyrica","guideline_body":"FDA label","recommendation":"Pregabalin capsules are indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy.","line_of_therapy":"1L","evidence_grade":"A","guideline_year":null},{"drug_id":"lyrica","guideline_body":"FDA label","recommendation":"Pregabalin capsules are indicated for the management of postherpetic neuralgia.","line_of_therapy":"1L","evidence_grade":"A","guideline_year":null},{"drug_id":"lyrica","guideline_body":"FDA label","recommendation":"Pregabalin capsules are indicated for the management of fibromyalgia.","line_of_therapy":"1L","evidence_grade":"A","guideline_year":null},{"drug_id":"lyrica","guideline_body":"FDA label","recommendation":"Pregabalin capsules are indicated for the management of neuropathic pain associated with spinal cord injury.","line_of_therapy":"1L","evidence_grade":"A","guideline_year":null}],"source":"Drug Landscape verified database"}